Clearside Biomedical Inc (CLSD) — Capital Reinvestment Ratio

Latest as of December 2023: 0.24x

Clearside Biomedical Inc (CLSD) has a Capital Reinvestment Ratio of 0.24x as of December 2023, meaning it reinvests 0% of its operating cash flow ($495.00K) in capital expenditures ($120.00K). See Clearside Biomedical Inc (CLSD) net asset quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.24x

Capex / Operating Cash Flow

Operating Cash Flow

$495.00K

USD

Capital Expenditures

$120.00K

USD

Data as of

Dec 2023

Most recent filing

Annual Capital Reinvestment Ratio for Clearside Biomedical Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Clearside Biomedical Inc from None to None. For live market cap and broader valuation context, see Clearside Biomedical Inc (CLSD) market capitalisation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow